AllianceBernstein’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107M | Sell |
2,470,558
-213,588
| -8% | -$9.22M | 0.03% | 364 |
|
|
2025
Q1 | $92.8M | Sell |
2,684,146
-110,146
| -4% | -$3.81M | 0.03% | 390 |
|
|
2024
Q4 | $76.7M | Sell |
2,794,292
-33,374
| -1% | -$916K | 0.03% | 481 |
|
|
2024
Q3 | $72M | Buy |
2,827,666
+375,262
| +15% | +$9.55M | 0.02% | 509 |
|
|
2024
Q2 | $62.1M | Sell |
2,452,404
-391,895
| -14% | -$9.93M | 0.02% | 542 |
|
|
2024
Q1 | $87.9M | Buy |
2,844,299
+286,883
| +11% | +$8.87M | 0.03% | 447 |
|
|
2023
Q4 | $103M | Sell |
2,557,416
-158,724
| -6% | -$6.41M | 0.04% | 391 |
|
|
2023
Q3 | $71.6M | Buy |
2,716,140
+2,560,549
| +1,646% | +$67.5M | 0.03% | 466 |
|
|
2023
Q2 | $2.68M | Buy |
155,591
+22,833
| +17% | +$393K | ﹤0.01% | 1745 |
|
|
2023
Q1 | $2.2M | Sell |
132,758
-200
| -0.2% | -$3.32K | ﹤0.01% | 1813 |
|
|
2022
Q4 | $1.01M | Hold |
132,958
| – | – | ﹤0.01% | 2264 |
|
|
2022
Q3 | $1.32M | Sell |
132,958
-185,258
| -58% | -$1.84M | ﹤0.01% | 2138 |
|
|
2022
Q2 | $2.89M | Sell |
318,216
-38,516
| -11% | -$350K | ﹤0.01% | 1725 |
|
|
2022
Q1 | $3.62M | Sell |
356,732
-60,198
| -14% | -$611K | ﹤0.01% | 1731 |
|
|
2021
Q4 | $6.95M | Buy |
416,930
+279,232
| +203% | +$4.66M | ﹤0.01% | 1436 |
|
|
2021
Q3 | $6.45M | Buy |
137,698
+1,750
| +1% | +$82K | ﹤0.01% | 1468 |
|
|
2021
Q2 | $8.29M | Sell |
135,948
-2,410
| -2% | -$147K | ﹤0.01% | 1320 |
|
|
2021
Q1 | $8.52M | Buy |
138,358
+34,374
| +33% | +$2.12M | ﹤0.01% | 1269 |
|
|
2020
Q4 | $7.39M | Hold |
103,984
| – | – | ﹤0.01% | 1277 |
|
|
2020
Q3 | $3.9M | Sell |
103,984
-2,433
| -2% | -$91.3K | ﹤0.01% | 1466 |
|
|
2020
Q2 | $3.47M | Buy |
106,417
+6,800
| +7% | +$222K | ﹤0.01% | 1527 |
|
|
2020
Q1 | $2.89M | Buy |
99,617
+72,164
| +263% | +$2.09M | ﹤0.01% | 1455 |
|
|
2019
Q4 | $962K | Buy |
+27,453
| New | +$962K | ﹤0.01% | 2288 |
|